15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $40M | -$882000 | 73.5% | -4.5% | -$6M | — | $7M |
| 2024 | $43M | $572000 | 74.0% | -3.0% | -$3M | — | $14M |
| 2023 | $44M | $568000 | 74.6% | -3.8% | -$4M | — | $56M |
| 2022 | $49M | $313000 | 74.2% | -0.5% | -$5M | — | $70M |
| 2021 | $60M | $1M | 75.0% | 2.6% | $791000 | — | $84M |
| 2020 | $62M | $843000 | 72.6% | 1.1% | $2M | — | $92M |
| 2019 | $78M | -$6M | 74.1% | -9.0% | -$19M | — | $96M |
| 2018 | $192M | $31M | 79.5% | 17.6% | $29M | — | $133M |
| 2017 | $198M | $24M | 80.4% | 21.8% | $26M | — | $135M |
| 2016 | — | $55M | — | — | — | — | $126M |
| 2015 | — | $47M | — | — | — | — | $105M |
| 2014 | — | $20M | — | — | — | — | $45M |
| 2013 | — | $4M | — | — | — | — | $15M |
| 2012 | — | $3M | — | — | $2M | — | $4M |
| 2011 | — | $2M | — | — | $1M | — | $2M |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $9M | -$154000 | 75.0% | -5.1% | -$912000 | — | $9M |
| Dec '25 | $10M | -$588000 | 72.9% | -6.5% | -$964000 | — | $7M |
| Sep '25 | $9M | -$431000 | 73.7% | -5.2% | $70000 | — | $14M |
| Jun '25 | $10M | $15000 | 73.9% | -3.4% | -$6M | — | $11M |
| Mar '25 | $11M | $122000 | 73.6% | -3.2% | $468000 | — | $22M |
| Dec '24 | $11M | $176000 | 74.2% | -3.9% | $68000 | — | $14M |
| Sep '24 | $11M | $35000 | 74.1% | -2.6% | -$443000 | — | $23M |
| Jun '24 | $10M | $173000 | 74.2% | -2.3% | -$4M | — | $16M |
| Mar '24 | $11M | $188000 | 73.4% | -3.3% | $538000 | — | $26M |
| Dec '23 | $11M | $358000 | 74.5% | -2.2% | -$83000 | — | $56M |
| Sep '23 | $11M | $172000 | 74.7% | -2.8% | -$887000 | — | $58M |
| Jun '23 | $11M | -$219000 | 74.6% | -7.1% | -$3M | — | $62M |
| Mar '23 | $12M | $257000 | 74.4% | -3.3% | -$703000 | — | $67M |
| Dec '22 | $13M | $188000 | 73.9% | 0.3% | $925000 | — | $70M |
| Sep '22 | $12M | $47000 | 73.6% | -1.2% | -$2M | — | $71M |
| Jun '22 | $13M | $183000 | 74.6% | 1.6% | -$1M | — | $76M |
| Mar '22 | $12M | -$105000 | 74.8% | -3.3% | -$2M | — | $79M |
| Dec '21 | $16M | $232000 | 74.2% | 3.0% | $2M | — | $84M |
| Sep '21 | $14M | $471000 | 74.3% | 3.4% | -$1M | — | $85M |
| Jun '21 | $16M | $229000 | 75.6% | 2.4% | $50000 | — | $88M |
How the market has priced NHTC against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, NATURAL HEALTH TRENDS CORP's revenue has declined 8.5% per year. These are computed facts, not advice.
As of FY2025, NATURAL HEALTH TRENDS CORP reported — of total debt against $7M of cash.
In FY2025, gross margin was 73.5%, operating margin -4.5%, and net margin -2.2%.
As of Jun '26, NATURAL HEALTH TRENDS CORP traded at a price-to-earnings ratio of about 43.9× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.